Medicare Enrolled

Dr. Imad El-Jassous, MD

Hematology · The Villages, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1400 N US HIGHWAY 441 STE 924, The Villages, FL 32159
3526338319
In practice since 2008 (17 years)
NPI: 1033374301 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. El-Jassous from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. El-Jassous? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. El-Jassous

Dr. Imad El-Jassous is a hematology in The Villages, FL, with 17 years in practice. Based on federal Medicare data, Dr. El-Jassous performed 130,212 Medicare services across 4,286 unique beneficiaries.

Between the years covered by Open Payments, Dr. El-Jassous received a total of $1,064 from 20 pharmaceutical and/or device companies across 56 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. El-Jassous is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 39% volume in FL$ $1,064 industry payments

Medicare Practice Summary

Medicare Utilization ↗
130,212
Medicare services
Top 39% in FL for hematology
4,286
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,660 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Feraheme)47,430$0$4
Iron infusion (Injectafer)18,000$1$3
Iron sucrose injection (Venofer)16,900$0$5
Denosumab injection (Prolia/Xgeva)12,600$18$51
Anti-nausea injection (aprepitant)9,230$1$5
Iron infusion (Monoferric)6,700$16$57
Epoetin alfa injection (Procrit) for anemia5,810$6$23
Blood draw (venipuncture)2,360$8$9
Complete blood count (CBC) with differential2,295$8$29
Dexamethasone injection (steroid)1,446$0$3
Drug injection, under skin or into muscle1,120$10$69
Anti-nausea injection (Aloxi/palonosetron)960$1$28
Office visit, established patient (10-19 min)857$41$147
Office visit, established patient (20-29 min)697$65$239
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg576$1$6
Anti-nausea injection (ondansetron/Zofran)400$0$9
Administration of chemotherapy into vein, 1 hour or less386$97$378
Injection of additional new drug or substance into vein374$12$61
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less282$47$189
Injection, carboplatin, 50 mg200$2$41
Initial hospital admission, high complexity173$137$556
Administration of chemotherapy into vein, each additional hour106$22$79
Injection, zoledronic acid, 1 mg102$7$69
Infusion into a vein for hydration, each additional hour96$9$42
Injection, methylprednisolone sodium succinate, up to 40 mg94$3$11
Injection of drug or substance into vein90$28$156
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle85$53$206
Office visit, established patient (30-39 min)79$97$339
Injection, diphenhydramine hcl, up to 50 mg70$1$3
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour68$15$56
Prothrombin time test (blood clotting)66$4$15
New patient office visit (30-44 min)64$82$298
Infusion, normal saline solution , 1000 cc64$2$7
Administration of additional new drug or substance into vein, 1 hour or less61$49$178
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional61$16$59
Hospital follow-up visit, moderate complexity57$63$197
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less53$22$84
Infusion into a vein for hydration, 31-60 minutes48$24$156
Infusion, normal saline solution, sterile (500 ml = 1 unit)39$1$7
Automated urinalysis35$2$8
Drawing of blood for a medical problem34$62$277
New patient office visit (45-59 min)32$131$453
New patient office or other outpatient visit, 15-29 minutes12$43$204
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
55.9% high complexity
38.8% medium
5.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,064
Total received (2018-2024)
Avg $177/year across 6 years
Bottom 17% in FL for hematology
20
Companies
56
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,052 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$597
2023
$119
2022
$69
2020
$20
2019
$155
2018
$105

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$254
Celgene Corporation
$202
Janssen Biotech, Inc.
$114
Bayer HealthCare Pharmaceuticals Inc.
$86
Merck Sharp & Dohme Corporation
$46
Astellas Pharma US Inc
$44
Genentech USA, Inc.
$43
E.R. Squibb & Sons, L.L.C.
$41
ABBVIE INC.
$41
PFIZER INC.
$32
JAZZ PHARMACEUTICALS INC.
$27
ARRAY BIOPHARMA INC
$24
Aurobindo Pharma USA, Inc.
$20
Janssen Pharmaceuticals, Inc
$16
AstraZeneca Pharmaceuticals LP
$14
Daiichi Sankyo Inc.
$13
Amgen Inc.
$13
MEDIVATION FIELD SOLUTIONS LLC
$13
Rigel Pharmaceuticals, Inc.
$12
GENZYME CORPORATION
$11
Top 3 companies account for 53.5% of total payments
Associated products mentioned in payments ›
Aliqopa · BOSULIF · CARVYKTI · DARZALEX · Fabhalta · KEYTRUDA · KISQALI · LIBTAYO · LYNPARZA · MEKINIST · ONUREG · OPDIVO · OPDUALAG · PLUVICTO · PROMACTA · Padcev · Polivy · Pomalyst · REBLOZYL · RYBREVANT · SCEMBLIX · TECVAYLI · Tavalisse · Tecentriq · VENCLEXTA · Vanflyta · Vitrakvi · XALKORI · XARELTO · XTANDI · ZEPZELCA · Zevalin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1 per 100 Medicare services performed
Looking for a hematology in The Villages?
Compare hematologys in the The Villages area by procedure volume, costs, and industry payment transparency.
Browse hematologys nearby

Geographic Context

Hematologys within 10 mi
9
Per 100K population
2.3
County median income
$69,956
Nearest hospital
VILLAGES REGIONAL HOSPITAL, THE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. El-Jassous is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. El-Jassous experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. El-Jassous performed 47,430 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. El-Jassous receive payments from pharmaceutical companies?
Yes. Dr. El-Jassous received a total of $1,064 from 20 companies across 56 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. El-Jassous's costs compare to other hematologys in The Villages?
Dr. El-Jassous's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. El-Jassous) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →